Opinions Benj Gallander
Telesta Therapeutics IncTST.TODON'T BUYSep 26, 2013
$0.28
Stock price when the opinion was issued
biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
You might be interested:
BUY
A very interesting company. Has an animal health product, human health products focused on bladder cancer and a vaccine for cattle. Likes the company, has existing products (short-term revenue stream) and has future opportunity and a potential blockbuster product. A significant opportunity.
biotechnologypharmaceutical
On his Stock Watch list. He knows there have been some agreements between management and some of the investors, which he feels bodes well for the company. At this point in time, he is not willing to jump in. They still have to deal with some internal things before it would be of more interest to him.